- Report
- October 2024
- 181 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Report
- August 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
Dirithromycin is an antibiotic used to treat a variety of bacterial infections. It belongs to the macrolide class of antibiotics, which work by inhibiting the growth of bacteria. Dirithromycin is used to treat respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases. It is also used to prevent certain types of bacterial infections in people who are at risk of developing them. Dirithromycin is available in both oral and intravenous forms.
The market for Dirithromycin is highly competitive, with many companies offering the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Other companies that produce Dirithromycin include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more